Frontlight ResearchEarly access
CompletedNo phase
Reducing Tobacco Smoking: a Transcranial Direct Current Stimulation (TDCS) Telehealth Study
Key facts
- Who runs it
- Wake Forest University Health Sciences
- Where
- Winston-Salem, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 43 people enrolled
- Started
- 15 Aug 2023
- Ended
- 22 Jan 2026
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Transcranial Direct Current Stimulation (tDCS)
- Mindfulness
- Sham - Transcranial Direct Current Stimulation (tDCS)
- Record updated
- 29 May 2026
Who can take part
- Age
- 21 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 21 criteriaShow less
Who can take part
- 21-75 years old
- Smoke ≥5 cigarettes per day and express interest in quitting smoking in next 30 days
- Mild to moderate distress defined as K10 scores 10-35
- Self reported previous diagnosis of cancer
- Psychotropic medication stable for ≥1 month prior to enrollment and throughout the trial, at the discretion of the study physician
- Access to a reliable internet connection, able to use mobile device, and complete online questionnaires, competent in instrumental activities of daily living
- Able to read and understand informed consent and questionnaires in English (WRAT-4 score≥85)
Who cannot take part
- Changes in health information over the course of enrollment in the study which place the participant at higher risk for an adverse event (as determined by Study Physician or Principal Investigator; e.g. medication changes, invasive procedures)
- Current use of prescription or over the counter smoking cessation medication, or primary use of non-combustible forms of nicotine/tobacco
- Currently receiving intravenous chemotherapy or radiation treatments
- Enrolled in group or individual therapy for smoking cessation that would be concurrent to intervention
- Current severe major depressive disorder, lifetime history of psychotic disorders or bipolar disorder type I, or current suicidal ideation
- Currently meets DSM-5 criteria for severe substance use disorder in the past 6 months for any psychoactive substance other than tobacco
- Any skin disorder or skin sensitive area near stimulation locations
- History of traumatic brain injury, brain metastases, seizure disorder, recent (<5 years) seizure history, or a neurodegenerative disease or neurocognitive disorder associated with significant impairment (e.g. Parkinson's, Dementia)
- Inability to effectively use study-provided supplies
- Chronic non-compliance with study procedures
- Temporary or permanent obstructions to making contact between the electrodes and the scalp (e.g. wig that the participant is not willing to remove)
- Current suicidal ideation (as determined by the MINI)
- Presence of metal objects in the head/neck
- Self-reported pregnancy
Where in United States
- Wake Forest University Health SciencesWinston-Salem, United States
About the trial
What the trial wants to find out
The study aims to evaluate the feasibility of using Dorsolateral Prefrontal Cortex (DLPFC) Transcranial Direct Current Stimulation (tDCS) as a tool to decreasing distress and cigarette smoking. 46 participants currently smoking cigarettes, and seeking to decrease cigarette use will be recruited.
The 2 groups in the trial
- Active tDCS + MindfulnessTreatment being tested
Treatment: Transcranial Direct Current Stimulation (tDCS) and Mindfulness
- Sham tDCS + MindfulnessSham treatment, for comparison
Treatment: Mindfulness and Sham - Transcranial Direct Current Stimulation (tDCS)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Reducing Distress and Tobacco Smoking in Cancer Survivors: a TDCS Telehealth Study
- Record updated
- 29 May 2026